ORPP logo
Image from Google Jackets

Innovation and the Pharmaceutical Industry : Critical Reflections on the Virtues of Profit.

By: Contributor(s): Material type: TextTextPublisher: Salem : Scrivener Publishing, 2008Copyright date: ©2008Edition: 1st edDescription: 1 online resource (253 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9780980209471
Subject(s): Genre/Form: Additional physical formats: Print version:: Innovation and the Pharmaceutical IndustryDDC classification:
  • 338.4/791510973
LOC classification:
  • HD9665.5 -- .I55 2008eb
Online resources:
Contents:
Intro -- Contents -- Preface -- I. Introduction -- Pharmaceutical Innovation and the Market: The Pursuit of Profit and the Amelioration of the Human Condition -- II. The Social Responsibility of Pursuing Profit -- The Unavoidable Goodness of Profit: The Cunning of Reason and the Realization of Human Well-Being -- Corporate Social Responsibility and Business Ethics in the Pharmaceutical Industry -- Pharmaceutical Companies and Their Obligations to Developing Countries: Psychopaths or Scapegoats? -- III. Autonomy, Advertising, and Pharmaceutical Costs -- Autonomy, Constraining Options, and Pharmaceutical Costs -- Pharmaceutical Advertising and Patient Autonomy -- IV. Some Criticisms of the Pharmaceutical Industry Critically Re-examined -- Why America Does Not Have a Second Drug Problem -- Global Drug Innovation in a World of Financial Finitude: Retailing Virtue to Promote Capital Formation and Profit -- V. Markets, Pharmaceuticals, and Health Savings Accounts -- Time, Money and the Market for Drugs -- Perils of Parallel Trade: Reimporting Prescription Drugs from Canada to the US -- VI. Pharmaceutical Liability: Another Source of Health Care Costs -- Risk, Responsibility, and Litigation -- Contributors -- Index.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Intro -- Contents -- Preface -- I. Introduction -- Pharmaceutical Innovation and the Market: The Pursuit of Profit and the Amelioration of the Human Condition -- II. The Social Responsibility of Pursuing Profit -- The Unavoidable Goodness of Profit: The Cunning of Reason and the Realization of Human Well-Being -- Corporate Social Responsibility and Business Ethics in the Pharmaceutical Industry -- Pharmaceutical Companies and Their Obligations to Developing Countries: Psychopaths or Scapegoats? -- III. Autonomy, Advertising, and Pharmaceutical Costs -- Autonomy, Constraining Options, and Pharmaceutical Costs -- Pharmaceutical Advertising and Patient Autonomy -- IV. Some Criticisms of the Pharmaceutical Industry Critically Re-examined -- Why America Does Not Have a Second Drug Problem -- Global Drug Innovation in a World of Financial Finitude: Retailing Virtue to Promote Capital Formation and Profit -- V. Markets, Pharmaceuticals, and Health Savings Accounts -- Time, Money and the Market for Drugs -- Perils of Parallel Trade: Reimporting Prescription Drugs from Canada to the US -- VI. Pharmaceutical Liability: Another Source of Health Care Costs -- Risk, Responsibility, and Litigation -- Contributors -- Index.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

© 2024 Resource Centre. All rights reserved.